###begin article-title 0
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
Fat Mass-and Obesity-Associated (FTO) Gene Variant Is Associated With Obesity
###end article-title 0
###begin p 1
###xml 29 55 29 55 <email xmlns:xlink="http://www.w3.org/1999/xlink">nhlqi@channing.harvard.edu</email>
Corresponding author: Lu Qi, nhlqi@channing.harvard.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
OBJECTIVE-To examine the longitudinal association of fat mass-and obesity-associated (FTO) variant with obesity, circulating adipokine levels, and FTO expression in various materials from human and mouse.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 261 263 261 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 264 266 264 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 60 63 <span type="species:ncbi:9606">men</span>
###xml 74 79 <span type="species:ncbi:9606">women</span>
###xml 178 181 <span type="species:ncbi:9606">men</span>
###xml 196 201 <span type="species:ncbi:9606">women</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
RESEARCH DESIGN AND METHODS-We genotyped rs9939609 in 2,287 men and 3,520 women from two prospective cohorts. Plasma adiponectin and leptin were measured in a subset of diabetic men (n = 854) and women (n = 987). Expression of FTO was tested in adipocytes from db/db mice and mouse macrophages.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 414 415 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 510 511 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 597 600 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 722 724 708 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 725 727 711 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 734 737 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 115 118 <span type="species:ncbi:9606">men</span>
###xml 190 195 <span type="species:ncbi:9606">women</span>
###xml 542 547 <span type="species:ncbi:9606">women</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
RESULTS-We observed a trend toward decreasing associations between rs9939609 and BMI at older age (>/=65 years) in men, whereas the associations were constant across different age groups in women. In addition, the single nucleotide polymorphism (SNP) rs9939609 was associated with lower plasma adiponectin (log[e]- means, 1.82 +/- 0.04, 1.73 +/- 0.03, and 1.68 +/- 0.05 for TT, TA, and AA genotypes, respectively; P for trend = 0.02) and leptin (log[e]- means, 3.56 +/- 0.04, 3.63 +/- 0.04, and 3.70 +/- 0.06; P for trend = 0.06) in diabetic women. Adjustment for BMI attenuated the associations. FTO gene was universally expressed in human and mice tissues, including adipocytes. In an ancillary study of adipocytes from db/db mice, FTO expression was approximately50% lower than in those from wild-type mice.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 258 260 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 261 263 261 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
CONCLUSIONS-The association between FTO SNP rs9939609 and obesity risk may decline at older age. The variant affects circulating adiponectin and leptin levels through the changes in BMI. In addition, the expression of FTO gene was reduced in adipocytes from db/db mice.
###end p 6
###begin p 7
Published ahead of print at  on 22 July 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 188 196 <span type="species:ncbi:9606">children</span>
In a recent genome-wide association study, Frayling et al. (1) identified a common variant in fat mass-and obesity-associated (FTO) gene (rs9939609) that was related to higher BMI in both children and adults. In addition, adiposity appeared to mediate the association between FTO variant and the risk of type 2 diabetes (2,3). Several other studies have also observed associations between FTO variants and obesity-related traits in various populations (4-13).
###end p 9
###begin p 10
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 800 803 800 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 900 902 900 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 903 905 903 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 833 839 <span type="species:ncbi:9606">humans</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
Because most available data are cross-sectional, the longitudinal pattern of the associations between FTO variants and adiposity and age-specific genetic effects are not clearly defined. The primary aim of the present study is to address these issues by assessing the genetic effects in two prospective cohorts. Obesity status affects the endocrine function of adipose tissue by altering the secretion of adipokines, such as adiponectin and leptin, which have been related to ectopic fat accumulation, insulin sensitivity, and diabetes risk in epidemiological studies (14-16). We therefore examined the associations of FTO variant with circulating levels of adiponectin and leptin. In addition to the association analyses, to shed light on its potential functions, we also examined the expression of FTO gene in various tissues from humans and mice and investigated the expression in adipocytes from db/db mice and mice macrophages in response to inflammatory stimulants.
###end p 10
###begin title 11
RESEARCH DESIGN AND METHODS
###end title 11
###begin p 12
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 255 260 <span type="species:ncbi:9606">women</span>
###xml 484 487 <span type="species:ncbi:9606">men</span>
The Nurses' Health Study (NHS) was established in 1976 when 121,700 female registered nurses aged 30-55 years and residing in 11 large U.S. states completed a mailed questionnaire on their medical history and lifestyle (17). Between 1989 and 1990, 32,826 women provided blood samples. The Health Professional Follow-Up Study (HPFS) is a prospective cohort study of 51,529 U.S. male health professionals aged 40-75 years at study initiation in 1986 (18). Between 1993 and 1999, 18,159 men provided blood samples. Information about health and disease is assessed biennially by self-administered questionnaires in both cohorts.
###end p 12
###begin p 13
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
###xml 791 799 <span type="species:ncbi:9606">patients</span>
Diabetes cases were defined as self-reported diabetes confirmed by a validated supplementary questionnaire. For cases occurring before 1998, the diagnosis was made using criteria proposed by the National Diabetes Data Group (19). Medical record review confirmed 98% of the diagnoses. We used the American Diabetes Association diagnostic criteria for diagnosis after the 1998 cycles (20). Subjects for the present study were selected from those who provided blood samples and were free from cardiovascular disease or cancer at baseline. Healthy control subjects were matched on age and the time of blood drawing with diabetic patients. To reduce potential bias due to population stratification, we included only Caucasians of European ancestry. In total, 1,506 female and 1,076 male diabetic patients and 2,014 female and 1,211 male nondiabetic control subjects were included.
###end p 13
###begin title 14
Assessment of adiposity.
###end title 14
###begin p 15
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 617 618 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1132 1133 1132 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1155 1156 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1166 1168 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1169 1171 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 1210 1211 1206 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 54 66 <span type="species:ncbi:9606">participants</span>
###xml 721 733 <span type="species:ncbi:9606">participants</span>
At baseline (1976 for the NHS and 1986 for the HPFS), participants were asked to report their height and current body weight; the self-reported weight was then updated every 2 years during the follow-up through 2002 (1976, 1978, 1980, 1982, 1986, 1988, 1990, 1992, 1994, 1996, 1998, 2000, and 2002 in the NHS; and 1986, 1988, 1990, 1992, 1994, 1996, 1998, 2000, and 2002 in the HPFS) using self-administered questionnaires. To assess the adiposity in early adulthood, the 1980 NHS questionnaire asked about weight at 18 years of age (n = 3,337), and the 1986 HPFS questionnaire asked about weight at 21 years of age (n = 2,194). We calculated BMI as weight in kilograms divided by height squared in meters. In 1986-1987, participants in the NHS (n = 2,333) and HPFS (n = 1,898) reported direct measurements of their waists (at the umbilicus) and hips (at the largest circumference) to the nearest quarter of an inch, using a paper tape and detailed measuring directions. The validity of self-reported adiposity measures were assessed in a random sample living in the greater Boston area, with high correlation with measured weight (r >/= 0.96) and waist (r = 0.95) (21,22). We defined obesity as BMI >/=30 kg/m2.
###end p 15
###begin title 16
Assessment of biomarkers.
###end title 16
###begin p 17
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 175 178 <span type="species:ncbi:9606">men</span>
###xml 193 198 <span type="species:ncbi:9606">women</span>
Blood samples were collected between 1989 and 1990 in NHS and between 1993 and 1999 in HPFS, as previously described (23,24). Biomarkers were measured in a subset of diabetic men (n = 854) and women (n = 987). Plasma adiponectin concentration was measured by competitive radioimunoassay (RIA; Linco Research, St. Charles, MO) with a coefficient of variation (CV) of 3.4%. Leptin was assayed by RIA (Linco Research) with intra-assay CV of 3.4-8.3%. A1C values were determined based on turbidimetric immunoinhibition using hemolyzed whole blood or packed red cells. The day-to-day variability at A1C concentrations of 5.5 and 9.1% was 1.9 and 3.0%, respectively.
###end p 17
###begin title 18
Single nucleotide polymorphism selection and genotype determination.
###end title 18
###begin p 19
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 937 938 935 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
To date, five single nucleotide polymorphisms (SNPs) in FTO genes have been reported to be associated with obesity traits. These SNPs are in strong to perfect linkage disequilibrium. We therefore selected one SNP, rs9939609, which was found by the first genome-wide association (GWA) study, as a proxy for other SNPs (pairwise r2 with rs9939609: rs17817449, 1.00; rs1421085, 0.97; rs3751812, 1.00; and rs9930506, 0.84; HapMap, Centre d'Etude du Polymorphisme Humain [CEPH]). DNA was extracted from the buffy coat fraction of centrifuged blood using the QIAmp Blood kit (Qiagen, Chatsworth, CA). The SNP was genotyped using TaqMan SNP allelic discrimination by means of an ABI 7900HT (Applied Biosystems, Foster City, CA). The internal quality of genotype data was assessed by typing 10% blinded samples in duplicate; resulting concordance was >99%. The call rate was >95%, and genotype distribution was in Hardy-Weinberg equilibrium (chi2 test).
###end p 19
###begin title 20
Real-time RT-PCR and analyses of experimental data.
###end title 20
###begin p 21
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 133 135 133 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 136 138 136 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1441 1444 1433 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 1567 1570 1559 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 1637 1640 1629 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 221 226 <span type="species:ncbi:10090">Mouse</span>
###xml 348 353 <span type="species:ncbi:9606">Human</span>
###xml 475 480 <span type="species:ncbi:10090">Mouse</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 658 664 <span type="species:ncbi:9913">bovine</span>
###xml 926 931 <span type="species:ncbi:9606">Human</span>
###xml 1435 1440 <span type="species:ncbi:9606">human</span>
###xml 1466 1471 <span type="species:ncbi:10090">mouse</span>
###xml 1561 1566 <span type="species:ncbi:9606">human</span>
###xml 1631 1636 <span type="species:ncbi:10090">mouse</span>
Mouse tissues were collected from wild-type (n = 3; C57BL/6 strain mice obtained from The Jackson Laboratories [Bar Harbor, ME]) and db/db mice (n = 3, 3 months old, male), a genetic model of obesity and type 2 diabetes. Mouse 3T3-L1 adipocytes were differentiated in media containing insulin, dexamethasone, and isobutylmethylxanthine for 8 days. Human adipocytes were differentiated from preadipocytes (obtained from a cell line maintained by Cambrex) in a similar manner. Mouse macrophages were generated from bone marrow of wild-type mice as described previously (25). Macrophages were cultured in Dulbecco's modification of Eagle's medium and 10% fetal bovine serum and treated with gamma-interferon (IFN-gamma) at a dose of 2 ng/ml overnight. Lipopolysaccharide (LPS; 10 ng/ml) was then added for an additional 8 h. RNA was isolated using TRIzol (Invitrogen) and reverse transcribed with the Quantitect RT kit (Qiagen). Human tissue (brain, heart lung, liver, spleen, intestine, kidney, muscle, leukocytes, preadipocytes, and adipocytes) cDNAs were purchased from Clontech (multiple choice cDNA). SYBR green-based real-time PCRs were conducted using RealMasterMix (Eppendorf) and detected by the 7300 Real-Time PCR system (Applied Biosystems). The expression of the 36B4 gene, which is a housekeeping gene to serve as a control, was used for normalization to obtain relative expression levels. The slope of efficiency curves for human FTO gene is -3.4 and for mouse is -3.6 (-4 means PCR product doubles each cycle). Oligo sequences used were as follows: human FTO, 5'-TTTAGTTCCACCCACCGAGT-3' and 5'-ACATTCTGCAGAGCCAACTG-3'; mouse FTO, 5'-ATCACGATGAGAACCTGGTG-3' and 5'-CCAACATGCCAAGTATCAGG-3'; and 36B4, 5'-AGATGCAGCAGATCCGCAT-3' and 5'-GTTCTTGCCCATCAGCACC-3'.
###end p 21
###begin p 22
###xml 68 69 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 122 123 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
For gene expression analyses, values are presented as means +/- SE (n = 3), and group means were compared using Student's t test. The SAS statistical package was used for the analyses (SAS, version 8.2 for UNIX). Statistical significance was set at the 0.05 level, and all tests were two-tailed.
###end p 22
###begin title 23
Statistical analyses.
###end title 23
###begin p 24
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 820 821 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 697 702 <span type="species:ncbi:9606">women</span>
###xml 1057 1065 <span type="species:ncbi:9606">patients</span>
###xml 1185 1190 <span type="species:ncbi:9606">women</span>
Similar associations between FTO SNP rs9939606 and BMI were previously reported in diabetic patients and control subjects (1) and were also observed in our cohorts. Thus, we pooled diabetic and nondiabetic subjects in the analyses. The geometric means of BMI and waist circumference were compared among the genotypes using general linear models, adjusting for age and diabetes status. In the multivariable analyses, we also adjusted for physical activity (quintiles), smoking (never, past, and current), alcohol intake (nondrinker and drinker [0.1-4.9, 5-10, or >10 g/day]), family history of diabetes (yes/no), and menopausal status (pre- or postmenopausal [never, past, or current hormone use]; women only). Crude associations between genotype and binary outcomes (obesity and diabetes) were tested using Pearson's chi2 statistic, and unconditional logistic regression was used to test for association after adjusting for covariates. General linear models were used to compare the genotype difference in biomarkers (adiponectin and leptin) among diabetic patients, adjusting for age, BMI, physical activity, smoking, alcohol intake, duration of diabetes, A1C, and menopausal status (women only). Plasma adiponectin and leptin levels were logarithmically transformed to achieve a normal distribution. The geometric means of the back-transformed values were presented.
###end p 24
###begin p 25
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
We used generalized estimating equations (GEEs) to analyze the associations between the genotypes and longitudinal BMI values (26,27). The analysis used the biennially collected repeated measurements of BMI from 1976 to 2002 in the NHS and from 1986 to 2002 in the HPFS. We used exchangeable correlation structure to account for the correlation of the repeated measures. Interaction between genotype and age was tested by creating a product term of the two variables in the model.
###end p 25
###begin title 26
RESULTS
###end title 26
###begin p 27
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 50 62 <span type="species:ncbi:9606">participants</span>
Table 1 shows the baseline characteristics of the participants by sex and diabetes status. The frequency of rs9939609 allele A in the study populations was 0.44, similar to the HapMap population frequency of 0.45 in the CEPH and other European populations (1,4).
###end p 27
###begin title 28
Associations with adiposity at early and middle adulthood.
###end title 28
###begin p 29
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 591 598 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 81 84 <span type="species:ncbi:9606">men</span>
###xml 89 94 <span type="species:ncbi:9606">women</span>
###xml 158 161 <span type="species:ncbi:9606">men</span>
###xml 166 171 <span type="species:ncbi:9606">women</span>
###xml 312 315 <span type="species:ncbi:9606">men</span>
###xml 320 325 <span type="species:ncbi:9606">women</span>
###xml 408 413 <span type="species:ncbi:9606">women</span>
###xml 455 458 <span type="species:ncbi:9606">men</span>
###xml 576 579 <span type="species:ncbi:9606">men</span>
###xml 584 589 <span type="species:ncbi:9606">women</span>
###xml 633 636 <span type="species:ncbi:9606">men</span>
Table 2 shows the associations of SNP rs9939609 with BMI (n = 2,236 and 3,483 in men and women, respectively) and waist circumference (n = 1,898 and 2,333 in men and women, respectively) in 1986/1987, when both measures were available in the NHS and HPFS, and with BMI at early adulthood (n = 2,194 and 3,337 in men and women, respectively). The SNP was associated with higher BMI and waist circumference in women, under an additive inheritance model. In men, rs9939609 was associated with a higher BMI. SNP rs9939609 was also associated with higher BMI at early adulthood in men and women (Table 2). Although the genetic effects in men seemed not to fit well with the additive model, testing for the departure from the additive model was not significant. Because smoking may affect adiposity, we excluded current smokers in sensitivity analyses but did not find appreciable changes in the associations.
###end p 29
###begin p 30
###xml 220 226 220 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 404 405 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 583 589 581 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 191 194 <span type="species:ncbi:9606">men</span>
###xml 199 204 <span type="species:ncbi:9606">women</span>
###xml 241 247 <span type="species:ncbi:9606">people</span>
###xml 268 271 <span type="species:ncbi:9606">men</span>
###xml 284 289 <span type="species:ncbi:9606">women</span>
###xml 424 427 <span type="species:ncbi:9606">men</span>
###xml 432 437 <span type="species:ncbi:9606">women</span>
###xml 549 552 <span type="species:ncbi:9606">men</span>
###xml 557 562 <span type="species:ncbi:9606">women</span>
We further assessed the relation between rs9939609 and obesity risk (in 1986/1987). The AA homozygotes were associated with 1.75 (1.26-2.45) and 1.71 (1.36-2.16) times higher obesity risk in men and women, respectively (Fig. 1). Because few people were obese (2.6% in men and 3.4% in women) at early adulthood, we examined the associations between FTO genotypes and the risk of overweight (BMI >/=25 kg/m2) instead. In both men and women, the AA homozygotes were associated with 1.57 (1.22-2.03) and 1.84 (1.40-2.40) times higher overweight risk in men and women at early adulthood (Fig. 1).
###end p 30
###begin title 31
Associations with longitudinal measurements of adiposity.
###end title 31
###begin p 32
###xml 236 242 236 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 77 82 <span type="species:ncbi:9606">women</span>
###xml 181 184 <span type="species:ncbi:9606">men</span>
###xml 383 388 <span type="species:ncbi:9606">women</span>
###xml 393 396 <span type="species:ncbi:9606">men</span>
###xml 432 435 <span type="species:ncbi:9606">men</span>
rs9939609 was associated with higher BMI during the 26 years of follow-up in women (1976-2002) and was associated with BMI at nearly all time points during 16 years of follow-up in men (1986-2002) except in 1988 and 1998 (supplementary Fig. 1, which is available in an online appendix at ). Similarly, the AA genotype was associated with greater obesity risk during the follow-up in women and men (except at 1992, 1996, and 2000 in men) (supplementary Fig. 2).
###end p 32
###begin p 33
###xml 126 133 126 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Figs. 2</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">3</xref>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 358 361 <span type="species:ncbi:9606">men</span>
###xml 366 371 <span type="species:ncbi:9606">women</span>
###xml 632 635 <span type="species:ncbi:9606">men</span>
###xml 729 732 <span type="species:ncbi:9606">men</span>
###xml 746 751 <span type="species:ncbi:9606">women</span>
In longitudinal analyses using GEEs, associations were observed between rs9939609 and BMI and the obesity risk in both sexes (Table 3). Each allele A was associated with 0.25 (SE = 0.11; P = 0.03) and 0.59 (SE = 0.13; P < 0.0001) kg/m2 higher BMI, as well as 1.21 (1.05-1.38)-fold (P = 0.007) and 1.19 (1.07-1.31)-fold (P = 0.0008) higher risk of obesity in men and women, respectively. We further examined whether the associations between SNP rs9939609 and adiposity were consistent across different age groups (Figs. 2 and 3). It appears that the association between the SNP and obesity risk declined with older age especially in men, although tests for interaction between genotypes and age were not significant (P = 0.20 for men and 0.08 for women).
###end p 33
###begin title 34
Case-control studies on type 2 diabetes.
###end title 34
###begin p 35
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 226 233 226 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t4">Table 4</xref>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 197 202 <span type="species:ncbi:9606">women</span>
###xml 550 553 <span type="species:ncbi:9606">men</span>
In the crude analyses, the TA and AA genotypes were associated, respectively, with a 1.17 (1.01-1.36)-fold and 1.24 (1.02-1.50)-fold higher risk of type 2 diabetes compared with the TT genotype in women (P for trend = 0.019) (Table 4). The associations between FTO genotypes and diabetes risk became nonsignificant when adjusted for BMI. However, adjusting for other diabetes risk factors, such as age, smoking, alcohol consumption, and physical activity, did not alter the association for diabetes. This SNP was not associated with diabetes risk in men.
###end p 35
###begin title 36
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Associations with adipokine concentrations in patients with type 2 diabetes.
###end title 36
###begin p 37
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 401 402 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 431 437 425 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 852 855 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 180 185 <span type="species:ncbi:9606">women</span>
###xml 194 197 <span type="species:ncbi:9606">men</span>
###xml 203 208 <span type="species:ncbi:9606">women</span>
###xml 810 813 <span type="species:ncbi:9606">men</span>
We further assessed whether FTO SNP rs9939609 was associated with adipose-secreted adipokines. We measured leptin and adiponectin in a subset of patients with type 2 diabetes (987 women and 854 men). In women, the FTO genotypes were associated with lower plasma adiponectin levels (log[10]-transformed means: 1.82 +/- 0.04, 1.73 +/- 0.03, and 1.68 +/- 0.05 for TT, TA, and AA genotypes, respectively; P = 0.02), adjusting for age (Fig. 4). The association remained when adjusted for smoking, alcohol consumption, physical activity, duration of diabetes, A1C, and menopausal status. Further adjustment for BMI attenuated the association. Allele A tended to be associated with higher leptin levels, with borderline significance. The genotype-associated difference in leptin disappeared when adjusted for BMI. In men, we did not find associations between FTO genotypes and adipokine levels.
###end p 37
###begin title 38
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
FTO gene expression profile and in tissues/cells with high metabolic capacities.
###end title 38
###begin p 39
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 204 210 204 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 475 477 475 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 478 480 478 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 579 580 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 573 580 561 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 598 601 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 705 706 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 699 706 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 290 296 <span type="species:ncbi:9606">humans</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 420 426 <span type="species:ncbi:9606">humans</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
To shed light on its potential role in adiposity, we conducted expression profiling of the FTO gene in human and mouse tissues and found similar expression patterns between the two species (supplementary Fig. 3). FTO was present at high levels in several metabolically active tissues (from humans and wild-type C56BL/6 mice), including brain, heart, kidney, and adipose tissue, with the highest expression in brain from humans and mice. In white adipose tissue isolated from db/db mice, FTO expression was reduced by approximately50% compared with lean wild-type controls (Fig. 5A). Interestingly, FTO is also expressed by macrophages and was induced by inflammatory stimulants, IFN-gamma, and LPS (Fig. 5B).
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 1011 1014 1011 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 106 109 <span type="species:ncbi:9606">men</span>
###xml 114 119 <span type="species:ncbi:9606">women</span>
###xml 402 407 <span type="species:ncbi:9606">women</span>
###xml 448 451 <span type="species:ncbi:9606">men</span>
###xml 947 950 <span type="species:ncbi:9606">men</span>
###xml 959 964 <span type="species:ncbi:9606">women</span>
In this study, we confirmed that the SNP rs9939609 was associated with higher BMI and obesity risk (1) in men and women from two independent U.S. cohorts. Frayling et al. (1) observed that the FTO genotype-associated difference in BMI occurred as early as 7 years old. We observed associations between FTO SNP and high BMI in early adulthood. The genetic effects were constant across different ages in women but tended to decrease at older ages in men. The mechanisms underlying this observation are not clear. A longitudinal twin study suggests that the genetic components regulating body weight may vary throughout life (28) and decrease with advanced age (29,30). Adiposity loss with age may partly explain the reduction in association at senior age. In addition, environmental influences accumulate with age and likely exert stronger influences on later BMI. It appears that the decreasing trend of BMI with advanced age is more pronounced in men than in women, but the test for interaction between sex and FTO was not statistically significant.
###end p 41
###begin p 42
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 3 8 <span type="species:ncbi:9606">women</span>
In women, rs9939609 was associated with greater risk of type 2 diabetes. Adjustment for BMI abolished the association. This finding is consistent with the observations from recent GWA studies (2,3), supporting the idea that obesity mediates the effects of FTO variant on the development of type 2 diabetes.
###end p 42
###begin p 43
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 656 664 <span type="species:ncbi:9606">patients</span>
Adipose tissue acts as endocrine organ through secreting hormone-like adipokines, which mediate the effects of obesity on various metabolic disorders (31). Adiponectin is the most abundant adipokine in the circulation (32). Adiponectin improves insulin action and metabolism of glucose and lipids (33,34). Low blood adiponectin levels have been related to increased risk of obesity and diabetes (35,36). Our data indicated that low adiponectin levels associated with the risk allele A were secondary to the changes in BMI and may partly mediate the genetic effects on diabetes risk. The association between FTO SNP and adiponectin was observed in diabetic patients. Future studies are warranted to replicate the findings in the general population.
###end p 43
###begin p 44
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
Little is known about the function of FTO gene. Our data comparing both human and mouse genes confirm high expression of FTO gene in brain (1). Gerken et al. (37) recently demonstrated that FTO was highly expressed in arcuate, paraventricular, dosomedial, and ventromedial nuclei. Of note, all of these sites are of critical importance in controlling energy balance. These data suggest FTO gene may affect the neuroregulation of energy balance. In addition, FTO expression was high in heart, kidney, and adipose tissues (particularly brown fat in mice).
###end p 44
###begin p 45
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 166 168 166 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 393 395 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 396 398 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 441 444 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 676 679 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 694 697 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 905 907 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 908 910 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 933 936 929 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
The expression of FTO was moderately increased in adipocytes compared with preadipocytes and was substantially reduced in white adipose tissues of obese, diabetic db/db mice, indicating that it may play a role in adipocyte function but not adipogenesis. The mechanism underlying the reduced expression of FTO in adipocytes from the genetic models with direct interruptions of the leptin axis (db/db mice) is not clear. The data suggest that FTO is likely a part of the pathway mediating the neuroregulation (e.g., leptin) of energy metabolism in adipose tissue, and blocking the leptin signal may inhibit the downstream changes in adipose tissue that induce the expression of FTO. Furthermore, FTO was found to be expressed in leukocytes and was drastically upregulated in macrophages stimulated with IFN-gamma and LPS. Given that metabolic dysregulation is recognized as a state of chronic inflammation (38,39), it is possible that FTO is a molecular link between metabolism and inflammation in the pathogenesis of obesity-related metabolic diseases.
###end p 45
###begin p 46
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
SNP rs9939609 is highly correlated with many other SNPs within a 47-kb region encompassing parts of the first two introns and exon 2 of FTO gene. Sequencing the chromosomes did not result in clear candidate functional variants in the FTO coding region, minimal splice sites, or 3'-untranslated region (1). Further work is warranted to explore the genetic mechanism underpinning the observed associations.
###end p 46
###begin p 47
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
Several limitations need to be acknowledged. Population stratification, mostly arising from either ethic admixture or genetic substructure within an ethnically homogenous group, may cause spurious associations. However, neither is likely to explain the associations observed in the present study. Our study populations are highly homogeneous by including only European whites. In addition, there is no evidence showing regional difference in rs9939606 across European countries (1).
###end p 47
###begin p 48
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 70 73 <span type="species:ncbi:9606">men</span>
###xml 78 83 <span type="species:ncbi:9606">women</span>
The participants in our study do not represent random samples of U.S. men and women. However, major cohort studies, such as the Framingham Heart Study, have also not relied on national samples. Clearly, data validity is the chief prerequisite that must be fulfilled before the results can be generalized. In previous analyses, the observed genetic and environmental associations for obesity, type 2 diabetes, coronary heart disease, and other diseases in our cohorts are very similar to those found in other broadly based U.S. populations (40-44). Nonetheless, the findings in the present study need to be replicated in other ethnic groups.
###end p 48
###begin p 49
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
Adiposity measures were self-reported in our cohorts. However, self-reported information has been reliably validated, with a high correlation with technician-measured variables (21,22). In addition, previous analyses in NHS and HPFS have demonstrated that self-reported BMI and waist circumference strongly predicted various chronic diseases (40,45,46).
###end p 49
###begin p 50
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
We examined only one SNP, rs9939609, which was reported by the original GWA study (1). Several other SNPs were associated with obesity in subsequent studies (4,5), but these SNPs are all in strong to perfect linkage disequilibrium with rs9939609. Thus, genotyping of these SNPs would have been redundant.
###end p 50
###begin p 51
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 341 343 341 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 344 346 344 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
In conclusion, we confirmed associations between the FTO SNP rs9939609 and higher obesity risk. Our data suggest that the genetic association for obesity may decline at older age. In addition, the genetic variant may affect circulating adiponectin levels through the changes in BMI. The expression of FTO gene was reduced in adipocytes from db/db mice. Little is known about the function of FTO gene, and thus, further investigation is warranted to identify the causal genetic variants and potential mechanisms underlying the observed genetic associations.
###end p 51
###begin title 52
Supplementary Material
###end title 52
###begin title 53
Online-Only Appendix
###end title 53
###begin p 54
L.Q. has received an American Heart Association Scientist Development Award and was supported by the Boston Obesity Nutrition Research Center (DK46200). C.-H.L. has received an American Heart Association Scientist Development Award. F.B.H. has received an American Heart Association Established Investigator Award. This work has been supported by National Institutes of Health Grants DK-58845 and CA-87969.
###end p 54
###begin title 55
REFERENCES
###end title 55
###begin p 56
###xml 47 48 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 96 97 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 154 157 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 211 214 <span type="species:ncbi:9606">men</span>
###xml 219 224 <span type="species:ncbi:9606">women</span>
Odds ratios (ORs) of overweight (BMI >/=25 kg/m2) at early adulthood and obesity (BMI >/=30 kg/m2) in 1986 associated with the TA and AA genotypes of the FTO SNP rs9939609 (T>A) compared with the AA genotype in men and women. Risk was adjusted for age and diabetes status. Error bars denote 95% CIs.
###end p 56
###begin p 57
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 163 164 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 249 250 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 302 303 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 95 98 <span type="species:ncbi:9606">men</span>
###xml 170 175 <span type="species:ncbi:9606">women</span>
The geometric means of BMI by the genotypes of FTO SNP rs9939609 in different age groups among men (<50, 50-54.9, 55-59.5, 60-64.9, 65-69.9, and >/=70 years old) (A) and women (<45, 45-49.5, 50-54.9, 55-59.5, 60-64.9, 65-69.9, and >/=70 years old) (B). The analyses were adjusted for diabetes status. *P < 0.05.
###end p 57
###begin p 58
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 197 198 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 283 284 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 129 132 <span type="species:ncbi:9606">men</span>
###xml 204 209 <span type="species:ncbi:9606">women</span>
ORs of obesity associated with the TA and AA genotypes of FTO SNP rs9939609 compared with TT genotype in different age groups of men (<50, 50-54.9, 55-59.5, 60-64.9, 65-69.9, and >/=70 years old) (A) and women (<45, 45-49.5, 50-54.9, 55-59.5, 60-64.9, 65-69.9, and >/=70 years old) (B). The analyses were adjusted for diabetes status. Error bars denote 95% CIs.
###end p 58
###begin p 59
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 128 133 <span type="species:ncbi:9606">women</span>
The geometric means (SEs) of plasma adiponectin and leptin levels (log-transformed) by the genotypes of FTO SNP rs9939609 among women with type 2 diabetes. The multivariate analyses were adjusted for age, physical activity (quintiles), smoking (never, past, and current), alcohol intake (nondrinker and drinker [0.1-4.9, 5-10, or >10 g/day]), duration of diabetes, A1C, and menopausal status (pre- or postmenopausal [never, past, or current hormone use]).
###end p 59
###begin p 60
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 122 124 122 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 211 213 211 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 214 216 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 548 549 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 385 390 <span type="species:ncbi:10090">mouse</span>
Regulation of FTO expression by genetic obesity and inflammatory stimulants. A: FTO is downregulated in adipose tissue of db/db mice. Adipose tissue was harvested from lean wild-type (n = 3) and obese, diabetic db/db mice (n = 3), and gene expression was determined by real-time RT-PCR. B: FTO is induced by proinflammatory stimulants in the macrophages. Bone marrow-derived wild-type mouse macrophages were incubated with or without 2 ng/ml IFN-gamma overnight followed by 10 ng/ml LPS treatment for 8 h. The experiments were done in triplicate. *P < 0.05.
###end p 60
###begin p 61
###xml 32 35 <span type="species:ncbi:9606">men</span>
###xml 40 45 <span type="species:ncbi:9606">women</span>
Baseline characteristics of the men and women from the HPFS and NHS
###end p 61
###begin p 62
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Data are n, means +/- SD, and percent. Cohort baseline, 1976 for the NHS and 1986 for HPFS; physical activity and alcohol consumption were obtained from the 1980 questionnaire in NHS.
###end p 62
###begin p 63
###xml 74 79 <span type="species:ncbi:9606">women</span>
###xml 110 113 <span type="species:ncbi:9606">men</span>
In hours of physical activity of at least moderate intensity per week for women and in MET hours per week for men.
###end p 63
###begin p 64
BMI and waist circumference (in cm) according to rs9939609 genotypes
###end p 64
###begin p 65
###xml 51 54 <span type="species:ncbi:9606">men</span>
###xml 68 73 <span type="species:ncbi:9606">women</span>
Data are means +/- SD. Except for early adulthood (men, age 21; and women, age 18), analyses were adjusted for age and diabetes status.
###end p 65
###begin p 66
Overall percentage of each genotype.
###end p 66
###begin p 67
###xml 74 77 <span type="species:ncbi:9606">men</span>
###xml 94 99 <span type="species:ncbi:9606">women</span>
GEE analyses on the associations between rs9939609 and BMI and obesity in men (1986-2002) and women (1976-2002)
###end p 67
###begin p 68
Data are means +/- SD or OR (95% CI).
###end p 68
###begin p 69
###xml 76 79 <span type="species:ncbi:9606">men</span>
###xml 84 89 <span type="species:ncbi:9606">women</span>
Associations between rs9939609 genotypes and the risk of type 2 diabetes in men and women
###end p 69
###begin p 70
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 403 408 <span type="species:ncbi:9606">women</span>
Data are n (%) and OR (95% CI). Model 1, crude analysis; model 2, adjusted for BMI; model 3, adjusted for other covariates than BMI, including age, physical activity (quintiles), smoking (never, past, and current), alcohol intake (nondrinker and drinker [0.1-4.9, 5-10, or >10 g/day]), family history of diabetes, and menopausal status (pre- or postmenopausal [never, past, or current hormone use]; for women only).
###end p 70

